Inventor · disambiguated record
Allen Cato
Also filed as: CATO ALLEN · CATO ALLEN E
9 granted patents·6 pending applications·2 citations·filing 2014–2024
81Inventor score
Top patents by PatentIndex Score
15 records- 0185US2025161251A1Dosage forms and therapeutic uses of l-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0280US11583576B2Compositions and methods for inducing humoral and cellular immunities against tumors and cancerCANCER ADVANCES INC·Filed 2018·Granted Feb 21, 2023·2 cites·11 claims
- 0379US12036198B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPUETICS INC·Filed 2022·Granted Jul 16, 2024·0 cites·18 claims
- 0476US2025242007A1Compositions and methods for inducing humoral and cellular immunities against tumors and cancerCANCER ADVANCES INC·Filed 2024·Application pending·0 cites
- 0575US12076383B2Compositions and methods for inducing humoral and cellular immunities against tumors and cancerCANCER ADVANCES INC·Filed 2022·Granted Sep 3, 2024·0 cites·9 claims
- 0673US2025319171A1Compositions and methods for preventing tumors and cancerCANCER ADVANCES INC·Filed 2024·Application pending·0 cites
- 0771US10632091B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·0 cites·6 claims
- 0870US10617663B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPUETICS INC·Filed 2018·Granted Apr 14, 2020·0 cites·9 claims
- 0970US9993450B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2014·Granted Jun 12, 2018·0 cites·3 claims
- 1065US10980758B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPUETICS INC·Filed 2018·Granted Apr 20, 2021·0 cites·6 claims
- 1164US9993453B2Dosage forms and therapeutic uses L-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2016·Granted Jun 12, 2018·0 cites·11 claims
- 1263US12150978B2Compositions and methods for preventing tumors and cancerCANCER ADVANCES INC·Filed 2021·Granted Nov 26, 2024·0 cites·26 claims
- 1355US2024398917A1Compositions and methods for preventing tumors and cancerCANCER ADVANCES INC·Filed 2022·Application pending·0 cites
- 1453US2023398196A1Compositions and methods for enhancing t cell penetration of tumors and cancersCANCER ADVANCES INC·Filed 2021·Application pending·0 cites
- 1547US2018140568A1Therapeutic uses of l-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Allen Cato files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →